Jul 29, 2026 06:47AM
Jul 29, 2026 05:35AM
Jul 28, 2026 07:11AM
Jul 23, 2026 07:25AM
Jul 22, 2026 06:00AM
Jul 7, 2026 06:26AM
Jun 1, 2026 04:29PM Wolfe Research Assumes Repligen (RGEN) at Outperform
Jun 1, 2026 07:26AM
May 14, 2026 04:26PM
May 5, 2026 07:12AM
Apr 17, 2026 07:31AM
Apr 17, 2026 03:28AM
Mar 23, 2026 06:44AM
Mar 20, 2026 06:05AM Evercore: ' Latest Survey Work Positions 2026 As Better Year For Biopharma Spending'
Feb 25, 2026 08:32AM
Feb 24, 2026 07:36AM
Jan 16, 2026 09:37AM
Jan 8, 2026 09:30AM
Jan 6, 2026 07:31AM
Dec 16, 2025 07:30AM
Dec 8, 2025 07:11AM KeyBanc on Life Sciences Tools & Services: 'We Highlight Our Favored 2026 "Tools" Stocks'
Nov 12, 2025 08:43AM
Oct 28, 2025 01:41PM
Oct 28, 2025 07:33AM
Oct 1, 2025 03:55AM
Sep 23, 2025 07:29AM
Sep 23, 2025 07:26AM
Sep 22, 2025 06:02AM Evercore ISI Upgrades Repligen (NASDAQ: RGEN) to Outperform (correction)
Sep 17, 2025 07:53AM
Sep 16, 2025 08:39AM
Sep 11, 2025 04:06PM
Sep 3, 2025 06:47AM
Jul 30, 2025 08:47AM
Jul 29, 2025 07:32AM
Jun 24, 2025 06:18AM Barclays Starts Repligen (RGEN) at Overweight
Jun 16, 2025 08:02AM
Jun 9, 2025 03:28PM
May 30, 2025 12:34PM
Apr 29, 2025 04:03PM
Apr 29, 2025 03:58PM
Apr 29, 2025 02:54PM
Apr 29, 2025 07:33AM Repligen (RGEN) Tops Q1 EPS by 4c, provides guidance
Mar 17, 2025 04:05PM
Mar 4, 2025 09:50AM
Mar 4, 2025 07:32AM
Feb 28, 2025 10:02AM
Feb 24, 2025 08:42AM
Feb 21, 2025 06:46AM
Feb 21, 2025 06:37AM Repligen (RGEN) PT Raised to $170 at Canaccord Genuity
Feb 21, 2025 04:35AM

434,408 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All